![](/img/cover-not-exists.png)
468P Osimertinib in patients with T790M mutation positive advanced non-small cell lung cancer (NSCLC): Korean subgroup analysis from pooled phase II data
Ahn, M-J., Lee, J-S., Han, J-Y., Kim, D-W., Cho, B.C., Kang, J.H., Kim, S-W.Volume:
27
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw594.032
Date:
December, 2016
File:
PDF, 45 KB
2016